Home · Blog · Company Guides
Company Guides

Pharma Interview Questions: Scientific & Commercial Thinking

Pharmaceutical interviews test whether you can think like a scientist and a businessperson at once. This guide shows you exactly how to demonstrate both — with concrete example answers and a prep checklist.

13 June 2026 · 7 min read

Why Pharma Interviewers Test Both Scientific and Commercial Thinking

Pharmaceutical companies occupy a unique space: they are research-driven organisations that must also generate sustainable revenue. Whether you are applying for a role in medical affairs, clinical development, regulatory affairs, commercial operations, or market access, interviewers want evidence that you understand how science translates into patient value — and ultimately into business outcomes.

This dual expectation exists at every level. A junior medical science liaison must understand trial data deeply enough to discuss it credibly with a consultant, yet must also grasp why a particular molecule matters to the portfolio strategy. A commercial director must be able to challenge clinical assumptions, not just read a sales dashboard. Demonstrating both skills — fluently, and without being prompted — is what separates shortlisted candidates from the rest.

The Core Competencies Pharma Interviews Commonly Assess

While every company and role differs, pharma interviews tend to probe a consistent set of competencies. Understanding these in advance lets you map your experiences deliberately rather than hoping the right stories come to mind under pressure.

Scientific rigour covers your ability to critically evaluate data, understand study design limitations, interpret clinical endpoints, and communicate complex information accurately to different audiences. Commercial acumen covers market awareness, understanding of the drug development lifecycle and its costs, patient access considerations, pricing and reimbursement logic, and the ability to prioritise based on business impact. Cross-functional collaboration — working across R&D, regulatory, medical, and sales teams — is almost always assessed, because the development and launch of a medicine requires it.

  • Critical appraisal of clinical or scientific data
  • Understanding of the drug development pipeline (Phase I–IV, regulatory milestones)
  • Market access and health technology assessment (HTA) awareness
  • Customer and patient centricity
  • Stakeholder communication across scientific and non-scientific audiences
  • Risk assessment and decision-making under uncertainty

Common Pharma Interview Questions — and What They Are Really Asking

Pharma interviewers rarely ask only factual questions. Most questions are behavioural or hybrid, asking you to demonstrate competency through real experience. Below are frequently encountered question types alongside the underlying competency being probed.

"Tell me about a time you had to explain complex scientific data to a non-scientific audience." This tests scientific communication and commercial empathy — can you translate without distorting? "Describe a situation where commercial pressure conflicted with scientific or medical integrity. How did you handle it?" This tests ethical judgement and the ability to hold the line on evidence while remaining constructive. "How would you assess whether a new therapy is commercially viable?" This tests whether you connect efficacy data, unmet need, competitive landscape, and payer logic — not just the clinical profile. "Give an example of when you influenced a decision across a cross-functional team." This tests leadership without authority, a critical skill in matrix organisations.

Reading about it isn't the same as doing it on camera.

Run a free timed mock interview →

How to Use STAR to Bridge Science and Commerce

The STAR method (Situation, Task, Action, Result) is the standard structure for behavioural answers. In pharma, the most effective STAR answers weave scientific and commercial threads together rather than treating them separately. When describing your Result, always quantify where possible — and reference both dimensions.

Here is a concrete example answer for the question: "Tell me about a time you used scientific knowledge to influence a commercial decision."

  • Situation: "I was working as a medical science liaison when our regional commercial team was planning a promotional campaign focused heavily on overall response rate data from our lead trial."
  • Task: "My role was to ensure all promotional materials were scientifically accurate and medically compliant, but I also saw an opportunity to make the campaign more compelling to oncologists."
  • Action: "I reviewed the full data package and identified that progression-free survival data in a specific biomarker-positive subgroup was actually more clinically meaningful to the prescribers we were targeting. I put together a short evidence summary and presented it to the brand team, proposing we reframe the campaign narrative around that endpoint, with full regulatory review."
  • Result: "The updated campaign was approved and, after launch, field team feedback indicated significantly more substantive conversations with oncologists. The brand team subsequently included subgroup data analysis as a standing agenda item in their planning cycle."

Do's and Don'ts: Demonstrating Dual Thinking in the Room

Small habits in how you frame answers signal whether you are genuinely commercially minded or purely technically focused — and vice versa. The following contrasts capture the most common mistakes candidates make.

  • DO connect scientific findings to patient outcomes and then to market implications in a single answer — this shows integrated thinking.
  • DO reference the development lifecycle or regulatory context where relevant, even if not asked directly.
  • DO acknowledge uncertainty and trade-offs: "The Phase II data was promising but the sample size meant we had to be cautious about extrapolating to the broader population."
  • DON'T discuss a product purely in terms of mechanism of action without acknowledging its clinical positioning or competitive context.
  • DON'T discuss revenue or market share without grounding it in patient need or clinical evidence — it sounds purely transactional.
  • DON'T use jargon without immediately clarifying it; adapt your register to the interviewer in front of you.
  • DON'T give hypothetical answers when you have real experience — always anchor in what you actually did.

Preparing for Timed and Video-Format Pharma Interviews

Many pharmaceutical companies, particularly larger ones, now use asynchronous video interviews as a screening step. You record your answers to pre-set questions within a fixed time window — typically 90 seconds to three minutes — with no opportunity to ask for clarification or pause. These formats are cognitively demanding precisely because you must structure a complete, balanced answer quickly, without the natural back-and-forth of a live conversation.

Practising on camera under real time constraints is the single most effective way to prepare. ScreenReady simulates this format exactly, letting you record answers to pharma-relevant competency questions and receive AI feedback on structure, clarity, and whether your answer addresses both the scientific and commercial dimensions. Candidates who rehearse this way typically notice that their first attempts over-index on technical detail and under-deliver on commercial context — a pattern that is easy to correct once you can see and hear it.

Before any pharma interview, build a story bank of five to eight experiences that each demonstrate scientific rigour, commercial thinking, or both. Label each story by competency so you can retrieve the right one under pressure. Review the company's pipeline, recent regulatory approvals, and any public statements on therapeutic strategy — interviewers notice when candidates have done this, and it signals the commercial curiosity they are looking for.

Pre-Interview Checklist for Pharma Candidates

Use this checklist in the week before your interview to ensure you are prepared across both scientific and commercial dimensions.

  • Research the company's current pipeline: which phases are key assets in, and what are the anticipated regulatory milestones?
  • Identify the therapy area focus and understand the competitive landscape — who are the main competitors and how is this company differentiated?
  • Review relevant clinical trial data for lead products (public sources: ClinicalTrials.gov, published trial results, NICE technology appraisals).
  • Prepare at least two STAR stories that explicitly connect scientific evidence to a business or patient-access outcome.
  • Practise at least three answers on camera with a timer to simulate asynchronous video interview conditions.
  • Prepare two to three intelligent questions that show awareness of both scientific progress and commercial strategy.
  • Review the job description for competency language and mirror it naturally in your answers.

Frequently asked questions

How do I demonstrate commercial awareness if I have only worked in a scientific or academic role?

Focus on experiences where your scientific work had downstream implications: funding decisions, publication strategy, technology transfer, or stakeholder communication. Frame these outcomes in terms of impact and resource allocation. Show that you understand how your work connected to a broader objective, even if that objective was not purely revenue-driven.

What is the difference between a competency interview and a technical interview in pharma?

A competency interview asks you to demonstrate behaviours through past experience using structured answers (typically STAR format). A technical interview tests domain knowledge directly — for example, asking you to interpret a Kaplan-Meier curve or explain a regulatory submission process. Many pharma interviews combine both formats, sometimes in the same conversation, so prepare for each explicitly.

How much detail should I include about clinical data in a commercial role interview?

Enough to demonstrate credibility, but not so much that you lose the commercial thread. A useful rule: state the headline finding, acknowledge a key limitation or caveat, and then pivot to what it means for the market or for patients. This structure signals scientific literacy and commercial judgement simultaneously.

Are pharma video interviews scored differently from live interviews?

Companies do not publicly disclose their scoring methodologies, but asynchronous video interviews are generally assessed against the same competency frameworks as live interviews. The practical difference is that you cannot read the room, ask clarifying questions, or recover with a follow-up. Structure and conciseness matter even more, which is why timed practice is essential.

What questions should I ask at the end of a pharma interview?

Ask questions that reveal strategic curiosity: for example, how the company is approaching market access for a specific asset, how cross-functional teams are structured during a launch phase, or what success looks like in the first year of the role. Avoid questions answered easily on the company website — interviewers notice preparation, and its absence.

Practise for these companies

Put this into practice

ScreenReady builds a realistic, timed mock interview around your target role, records your answers on camera, and gives AI feedback on structure, evidence and delivery.

Start a free mock interview →